| Dr Ali Ahmad, MD | |
|
31-00 Broadway, Fair Lawn, NJ 07410-3963 | |
| (201) 693-4445 | |
| (201) 762-6109 |
| Full Name | Dr Ali Ahmad |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 19 Years |
| Location | 31-00 Broadway, Fair Lawn, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336425057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA08988400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlook Medical Center | Summit, NJ | Hospital |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Robert Wood Johnson University Hospital - Somerset | Somerville, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group Pa | 5395642276 | 1253 |
| Cardiovascular Health Consultants, P.a. | 8325934706 | 106 |
News Archive
A pre-diet measurement of two hormones related to weight regulation can help predict which dieters will be more likely to maintain their weight loss and who will not, according to a new study. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
While an FDA panel re-examines risks of amalgam over the next two days, the World Health Department is expected to release a key report soon recommending that amalgam use be "phased down" globally, consistent with its earlier recommendations.
Measurement of the pulmonary artery-to-aorta ratio can predict the risk for exacerbations in patients with chronic obstructive pulmonary disease, particularly those that require hospitalization, say the authors of a US study.
STMicroelectronics, a world leader in semiconductor solutions, and LifeNexus, the developer of the iChip™ and Personal Health Card, today announced that STMicroelectronics will produce the iChip microprocessor for the LifeNexus Personal Health Card.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 3 days ago
| Entity Name | Summit Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
A pre-diet measurement of two hormones related to weight regulation can help predict which dieters will be more likely to maintain their weight loss and who will not, according to a new study. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
While an FDA panel re-examines risks of amalgam over the next two days, the World Health Department is expected to release a key report soon recommending that amalgam use be "phased down" globally, consistent with its earlier recommendations.
Measurement of the pulmonary artery-to-aorta ratio can predict the risk for exacerbations in patients with chronic obstructive pulmonary disease, particularly those that require hospitalization, say the authors of a US study.
STMicroelectronics, a world leader in semiconductor solutions, and LifeNexus, the developer of the iChip™ and Personal Health Card, today announced that STMicroelectronics will produce the iChip microprocessor for the LifeNexus Personal Health Card.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 3 days ago
| Entity Name | Cardiovascular Health Consultants, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437291739 PECOS PAC ID: 8325934706 Enrollment ID: O20040224000028 |
News Archive
A pre-diet measurement of two hormones related to weight regulation can help predict which dieters will be more likely to maintain their weight loss and who will not, according to a new study. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
While an FDA panel re-examines risks of amalgam over the next two days, the World Health Department is expected to release a key report soon recommending that amalgam use be "phased down" globally, consistent with its earlier recommendations.
Measurement of the pulmonary artery-to-aorta ratio can predict the risk for exacerbations in patients with chronic obstructive pulmonary disease, particularly those that require hospitalization, say the authors of a US study.
STMicroelectronics, a world leader in semiconductor solutions, and LifeNexus, the developer of the iChip™ and Personal Health Card, today announced that STMicroelectronics will produce the iChip microprocessor for the LifeNexus Personal Health Card.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 3 days ago
| Entity Name | Garden State Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700014545 PECOS PAC ID: 8426190687 Enrollment ID: O20100126000693 |
News Archive
A pre-diet measurement of two hormones related to weight regulation can help predict which dieters will be more likely to maintain their weight loss and who will not, according to a new study. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
While an FDA panel re-examines risks of amalgam over the next two days, the World Health Department is expected to release a key report soon recommending that amalgam use be "phased down" globally, consistent with its earlier recommendations.
Measurement of the pulmonary artery-to-aorta ratio can predict the risk for exacerbations in patients with chronic obstructive pulmonary disease, particularly those that require hospitalization, say the authors of a US study.
STMicroelectronics, a world leader in semiconductor solutions, and LifeNexus, the developer of the iChip™ and Personal Health Card, today announced that STMicroelectronics will produce the iChip microprocessor for the LifeNexus Personal Health Card.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ali Ahmad, MD 31-00 Broadway, Fair Lawn, NJ 07410-3963 Ph: (201) 693-4445 | Dr Ali Ahmad, MD 31-00 Broadway, Fair Lawn, NJ 07410-3963 Ph: (201) 693-4445 |
News Archive
A pre-diet measurement of two hormones related to weight regulation can help predict which dieters will be more likely to maintain their weight loss and who will not, according to a new study. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
While an FDA panel re-examines risks of amalgam over the next two days, the World Health Department is expected to release a key report soon recommending that amalgam use be "phased down" globally, consistent with its earlier recommendations.
Measurement of the pulmonary artery-to-aorta ratio can predict the risk for exacerbations in patients with chronic obstructive pulmonary disease, particularly those that require hospitalization, say the authors of a US study.
STMicroelectronics, a world leader in semiconductor solutions, and LifeNexus, the developer of the iChip™ and Personal Health Card, today announced that STMicroelectronics will produce the iChip microprocessor for the LifeNexus Personal Health Card.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 3 days ago
Dr. Karen Balonze, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 31-00 Broadway, Fair Lawn, NJ 07410 Phone: 201-796-2255 Fax: 201-796-7020 | |
Dr. Ritesh Kalra, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 15-01 Broadway Ste 8, Fair Lawn, NJ 07410 Phone: 201-796-8060 Fax: 201-796-8070 | |
Rahul Agarwal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 31-00 Broadway, Fair Lawn, NJ 07410 Phone: 201-268-7415 Fax: 551-455-6780 | |
Dr. Lawrence Joseph Berman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 20-20 Fair Lawn Ave, Fair Lawn, NJ 07410 Phone: 201-703-0202 Fax: 201-703-1231 | |
Dr. Raghunandan S Loganathan, MD, FCCP Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 31-00 Broadway, Fair Lawn, NJ 07410 Phone: 973-777-7377 Fax: 973-777-3806 | |
Dima Yeshou, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12-04 Saddle River Rd, Fair Lawn, NJ 07410 Phone: 201-773-8710 Fax: 201-773-8711 | |
Dr. Christine Aquino, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 31-00 Broadway, Fair Lawn, NJ 07410 Phone: 201-796-2255 Fax: 201-796-7020 |